Octreotide Bendalis (Octreotide Acetate)

Octreotide acetate, the active ingredient in Octreotide Bendalis, is a somatostatin analog presented as a formulation for injection use. It regulates hormone secretion and is employed in the management of certain endocrine disorders and tumor‑related conditions in adults.

GNH USA supplies Octreotide Bendalis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and oncology centres worldwide.

Octreotide Bendalis is a somatostatin analog that modulates hormone‑driven pathways in several clinical settings. - Acromegaly: Reduces excess growth hormone levels and associated tissue overgrowth. - Neuroendocrine tumors: Controls hormone‑related flushing and diarrhea. - Carcinoid syndrome: Alleviates flushing, wheezing and diarrhoea. - Post‑operative post‑pancreatic surgery: Helps prevent pancreatic fistula formation. - Diagnostic imaging: Enhances the quality of somatostatin receptor scintigraphy scans. - Bleeding var var var var var 

Octreotide  ​  ​  ...